Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer
Sven Rottenberg(University of Bern), Piet Borst(The Netherlands Cancer Institute), Olaf van Tellingen(Dutch Cancer Society), Ingrid van der Heijden, Karin E. de Visser(Leiden University Medical Center), Jos Jonkers(The Netherlands Cancer Institute), Anders O.H. Nygren(Asana Biosciences (United States)), Koen van de Wetering(Thomas Jefferson University), Marina Pajic(University of Glasgow), Xiaoling Liu, Fijs W. B. van Leeuwen(Leiden University Medical Center), Jan P. Schouten(University Hospital Foundation), Kenneth G. A. Gilhuijs(Heidelberg University)
Cited by 304
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
|Nature|2015|1.7k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
|Nature Structural & Molecular Biology|2010|1k